Showing results (1001-1010 of 3,033) with videos related to
Sort By:
Pageof 304
International Journal of Clinical Pharmacology and Therapeutics|February 26, 2019
Pharmacokinetics and bioequivalence of two fenofibrate choline formulations in healthy subjects under fed and fasted conditionJi-Min Park, Soo-In Chae, Young Su Noh, et al.International Journal of Clinical Pharmacology and Therapeutics|September 7, 2019
Fatal outcome of atezolizumab in a patient with immune-mediated pneumonitis, thrombocytopenia, and cardiac dysfunction: A case reportJia Li, Xubin Deng, Birong Wang, et al.International Journal of Clinical Pharmacology and Therapeutics|March 11, 2021
Impact of urinary albumin excretion on the onset of adverse reactions to vancomycin hydrochlorideHiroshi Kimura, Akihiro Tanaka, Shinichi Watanabe, et al.International Journal of Clinical Pharmacology and Therapeutics|March 11, 2021
Pharmacokinetic comparison between tablet of varenicline tartrate and orally disintegrating film of varenicline salicylate in healthy subjectsEunwoo Kim, Jun Gi Hwang, Su Jun Park, et al.International Journal of Clinical Pharmacology and Therapeutics|March 25, 2011
Pharmacokinetics of vancomycin in neonates admitted to the neonatology unit at the Jordan University HospitalE F Badran, A Shamayleh, Y M IrshaidInternational Journal of Clinical Pharmacology and Therapeutics|March 25, 2011
Single-dose pharmacokinetics, pharmacodynamics and safety of AZD0837, a novel oral direct thrombin inhibitor, in young healthy male subjectsS Johansson, M Cullberg, U G Eriksson, et al.International Journal of Clinical Pharmacology and Therapeutics|May 6, 2011
Cyclosporine A area-under-time-concentration-curve in rheumatologic patients after the first dose. Which of the sparse sampling strategies will predict the best?B Koristkova, M Grundmann, D Suchy, et al.International Journal of Clinical Pharmacology and Therapeutics|May 6, 2011
Fatal lithium toxicity with therapeutic levels--a case reportP N Venkatarathnamma, A R Patil, N NanjundaiahInternational Journal of Clinical Pharmacology and Therapeutics|January 25, 2011
Exenatide - pharmacokinetics, pharmacodynamics, safety and tolerability in patients ≥ 75 years of age with Type 2 diabetesH Linnebjerg, P A Kothare, M Seger, et al.International Journal of Clinical Pharmacology and Therapeutics|January 25, 2011
Pharmacokinetic interaction between efavirenz and rifampicin in healthy volunteersYenny, Nafrialdi, Z Djoerban, et al.Pageof 304